• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

厚朴酚在抑制头颈癌细胞生长方面比和厚朴酚更具效力。

Honokiol Is More Potent than Magnolol in Reducing Head and Neck Cancer Cell Growth.

作者信息

Kleszcz Robert, Dorna Dawid, Stawny Maciej, Paluszczak Jarosław

机构信息

Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, 60-806 Poznań, Poland.

Department of Pharmaceutical Biochemistry, Doctoral School, Poznan University of Medical Sciences, 60-806 Poznań, Poland.

出版信息

Curr Issues Mol Biol. 2024 Sep 25;46(10):10731-10744. doi: 10.3390/cimb46100637.

DOI:10.3390/cimb46100637
PMID:39451517
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11506259/
Abstract

The efficacy of treatment of head and neck squamous cell carcinoma (HNSCC) patients is still unsatisfactory, and there is an ongoing search for novel therapies. Locoregionally advanced HNSCC cases, which frequently require combined surgery and chemoradiotherapy, are especially difficult to treat. Natural compounds, like -derived lignans-honokiol (HON) and magnolol (MAG)-can reduce cancer cell growth but retain a good safety profile and thus may show benefit as adjuvant therapeutics. The aim of this study was to evaluate the anti-cancer effects of HON and MAG in HNSCC cell lines and compare their effects between cisplatin-sensitive and cisplatin-tolerant cells. Cell viability was evaluated in FaDu and SCC-040 cells growing as monolayers and as spheroids. The effect of HON and MAG on the cell cycle, apoptosis, and gene expression was compared between wild-type FaDu cells and cisplatin persister FaDu cells. We observed that HON and MAG were more potent in reducing cell viability in cisplatin persister FaDu cells, although this effect was not directly followed by increased rates of apoptosis. Thus, HON's and MAG's capacity to affect cisplatin persister cells needs further studies. In general, we observed that HON exerted stronger cytotoxic effects than MAG in HNSCC cells, and the difference in their anti-cancer activity was especially pronounced in cells cultured in 3D.

摘要

头颈部鳞状细胞癌(HNSCC)患者的治疗效果仍不尽人意,人们一直在寻找新的治疗方法。局部晚期HNSCC病例通常需要联合手术和放化疗,治疗起来尤其困难。天然化合物,如源自木脂素的和厚朴酚(HON)与厚朴酚(MAG),可以抑制癌细胞生长,但安全性良好,因此可能作为辅助治疗药物显示出益处。本研究的目的是评估HON和MAG对HNSCC细胞系的抗癌作用,并比较它们在顺铂敏感和顺铂耐受细胞之间的效果。在单层生长和形成球体的FaDu和SCC-040细胞中评估细胞活力。比较了HON和MAG对野生型FaDu细胞和顺铂持续存在的FaDu细胞的细胞周期、凋亡和基因表达的影响。我们观察到,HON和MAG在降低顺铂持续存在的FaDu细胞的细胞活力方面更有效,尽管这种效果并没有直接导致凋亡率增加。因此,HON和MAG影响顺铂持续存在细胞的能力需要进一步研究。总体而言,我们观察到HON在HNSCC细胞中比MAG具有更强的细胞毒性作用,并且它们的抗癌活性差异在三维培养的细胞中尤为明显。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac39/11506259/af77b11ad127/cimb-46-00637-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac39/11506259/c5758a9bd981/cimb-46-00637-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac39/11506259/e84794cb1574/cimb-46-00637-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac39/11506259/bab65264d2b4/cimb-46-00637-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac39/11506259/0c7d15453d97/cimb-46-00637-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac39/11506259/08827f440de8/cimb-46-00637-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac39/11506259/af77b11ad127/cimb-46-00637-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac39/11506259/c5758a9bd981/cimb-46-00637-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac39/11506259/e84794cb1574/cimb-46-00637-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac39/11506259/bab65264d2b4/cimb-46-00637-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac39/11506259/0c7d15453d97/cimb-46-00637-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac39/11506259/08827f440de8/cimb-46-00637-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac39/11506259/af77b11ad127/cimb-46-00637-g006.jpg

相似文献

1
Honokiol Is More Potent than Magnolol in Reducing Head and Neck Cancer Cell Growth.厚朴酚在抑制头颈癌细胞生长方面比和厚朴酚更具效力。
Curr Issues Mol Biol. 2024 Sep 25;46(10):10731-10744. doi: 10.3390/cimb46100637.
2
Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor.厚朴酚通过靶向表皮生长因子受体抑制头颈部鳞状细胞癌的生长。
Oncotarget. 2015 Aug 28;6(25):21268-82. doi: 10.18632/oncotarget.4178.
3
Magnolol and honokiol target TRPC4 to regulate extracellular calcium influx and relax intestinal smooth muscle.厚朴酚和和厚朴酚靶向 TRPC4 以调节细胞外钙内流并使肠平滑肌松弛。
J Ethnopharmacol. 2022 May 23;290:115105. doi: 10.1016/j.jep.2022.115105. Epub 2022 Feb 11.
4
Inhibitory effects of magnolol and honokiol on human calcitonin aggregation.厚朴酚与和厚朴酚对人降钙素聚集的抑制作用。
Sci Rep. 2015 Sep 1;5:13556. doi: 10.1038/srep13556.
5
KDM5D Histone Demethylase Identifies Platinum-Tolerant Head and Neck Cancer Cells Vulnerable to Mitotic Catastrophe.KDM5D 组蛋白去甲基酶鉴定出对铂耐受的头颈部癌细胞,使其易发生有丝分裂灾难。
Int J Mol Sci. 2023 Mar 10;24(6):5310. doi: 10.3390/ijms24065310.
6
The Anticancer Application of Delivery Systems for Honokiol and Magnolol.厚朴酚与和厚朴酚递送系统的抗癌应用
Cancers (Basel). 2024 Jun 18;16(12):2257. doi: 10.3390/cancers16122257.
7
Magnolia polyphenols attenuate oxidative and inflammatory responses in neurons and microglial cells.玉兰多酚可减轻神经元和小胶质细胞的氧化应激和炎症反应。
J Neuroinflammation. 2013 Jan 29;10:15. doi: 10.1186/1742-2094-10-15.
8
Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice.长期补充厚朴酚和木兰醇可改善高脂喂养小鼠的体脂积累、胰岛素抵抗和脂肪炎症。
Mol Nutr Food Res. 2013 Nov;57(11):1988-98. doi: 10.1002/mnfr.201300113. Epub 2013 Jul 31.
9
Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas.厚朴酚与和厚朴酚通过自噬和凋亡对人胶质母细胞瘤发挥协同抗肿瘤作用。
Oncotarget. 2016 May 17;7(20):29116-30. doi: 10.18632/oncotarget.8674.
10
Emerging Phytochemicals for the Prevention and Treatment of Head and Neck Cancer.用于预防和治疗头颈癌的新型植物化学物质
Molecules. 2016 Nov 24;21(12):1610. doi: 10.3390/molecules21121610.

引用本文的文献

1
Formulation of Honokiol- and Magnolol-Loaded Nanoemulsions for Head and Neck Cancer Adjuvant Therapy: Evaluation of Radiation Sterilization Effects on Active Substance Properties.用于头颈癌辅助治疗的厚朴酚和和厚朴酚纳米乳剂的配方:辐射灭菌对活性物质性质影响的评估
Int J Mol Sci. 2025 Aug 20;26(16):8032. doi: 10.3390/ijms26168032.
2
Editorial for Special Issue "Phytochemicals in Cancer Chemoprevention and Treatment".《“植物化学物质在癌症化学预防与治疗中”特刊社论》
Curr Issues Mol Biol. 2025 Apr 18;47(4):289. doi: 10.3390/cimb47040289.

本文引用的文献

1
The Anticancer Application of Delivery Systems for Honokiol and Magnolol.厚朴酚与和厚朴酚递送系统的抗癌应用
Cancers (Basel). 2024 Jun 18;16(12):2257. doi: 10.3390/cancers16122257.
2
Triple Combinations of Histone Lysine Demethylase Inhibitors with PARP1 Inhibitor-Olaparib and Cisplatin Lead to Enhanced Cytotoxic Effects in Head and Neck Cancer Cells.组蛋白赖氨酸去甲基化酶抑制剂与PARP1抑制剂奥拉帕尼和顺铂的三联组合对头颈部癌细胞具有增强的细胞毒性作用。
Biomedicines. 2024 Jun 19;12(6):1359. doi: 10.3390/biomedicines12061359.
3
A Network Meta-Analysis of the Systemic Therapies in Unresectable Head and Neck Squamous Cell Carcinoma.
无法切除的头颈部鳞状细胞癌的系统治疗的网状荟萃分析。
Cancer Control. 2024 Jan-Dec;31:10732748241255535. doi: 10.1177/10732748241255535.
4
Recent advances of honokiol:pharmacological activities, manmade derivatives and structure-activity relationship.厚朴酚的最新进展:药理活性、人工衍生物及构效关系。
Eur J Med Chem. 2024 Jun 5;272:116471. doi: 10.1016/j.ejmech.2024.116471. Epub 2024 Apr 30.
5
Honokiol Suppresses Cell Proliferation and Tumor Migration through ROS in Human Anaplastic Thyroid Cancer Cells.厚朴酚通过活性氧抑制人间变性甲状腺癌细胞的增殖和肿瘤迁移。
Endocr Metab Immune Disord Drug Targets. 2024 Apr 24. doi: 10.2174/0118715303295608240408082523.
6
Delivery Strategies, Structural Modification, and Pharmacological Mechanisms of Honokiol: A Comprehensive Review.霍楠酚的递送策略、结构修饰及药理机制:全面综述。
Chem Biodivers. 2024 Jun;21(6):e202302032. doi: 10.1002/cbdv.202302032. Epub 2024 May 6.
7
Neuropharmacological potential of honokiol and its derivatives from Chinese herb Magnolia species: understandings from therapeutic viewpoint.厚朴酚及其从木兰属植物中提取的衍生物的神经药理学潜力:从治疗角度的理解
Chin Med. 2023 Nov 24;18(1):154. doi: 10.1186/s13020-023-00846-1.
8
Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy.免疫疗法时代对头颈癌新辅助和诱导治疗概念的再思考。
Cancer Treat Rev. 2023 Dec;121:102644. doi: 10.1016/j.ctrv.2023.102644. Epub 2023 Oct 12.
9
Honokiol and its analogues as anticancer compounds: Current mechanistic insights and structure-activity relationship.和厚朴酚及其类似物作为抗癌化合物:当前的机制见解和构效关系。
Chem Biol Interact. 2023 Dec 1;386:110747. doi: 10.1016/j.cbi.2023.110747. Epub 2023 Oct 8.
10
Natural Products as Anticancer Agents: Current Status and Future Perspectives.天然产物作为抗癌剂:现状与展望。
Molecules. 2022 Nov 30;27(23):8367. doi: 10.3390/molecules27238367.